Thalidomide prolongs experimental autoimmune neuritis in Lewis rats

Scandinavian Journal of Immunology

Volumn 48, Issue 4, 1998, Pages 397-402

  Zhu, J ^a   Deng, G M ^a   Diab, A ^a   Zwingenberger, K ^b   Bakhiet, M ^a   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b GRÜNENTHAL GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; THALIDOMIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; LYMPHOCYTE PROLIFERATION; MALE; NEURITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; ORAL DRUG ADMINISTRATION; POLYNEUROPATHY; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

ANIMALS; CATTLE; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; MYELIN SHEATH; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RATS; RATS, INBRED LEW; THALIDOMIDE;

EID: 0031721081     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00421.x     Document Type: Article

References (32)

1. Mellin GW, Katzenstein M. The saga of Thalidomide. N Engl J Med 1962;267:1184-93 and 1238-41.
2. Gutierrez-Rodriguez O, Starusta-Bacal P, Gutierrez-Montes O. Treatment of refractory rheumatoid arthritis - the thalidomide experience. J Rheumatol 1989;16:158-63.
3. Sarno EN, Grau GE, Vieira LM, Nery JA. Serum levels of tumour necrosis factor-α and interleukin-β during leprosy reactional states. Clin Exp Immunol 1991;84:103-8.
4. Vogelsang GB, Farmer ER, Hess AD, Gordon G. Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med 1992;326:1055-8.
5. Uthoff K, Zehr KJ, Gaudin PB. Thalidomide as replacement for steroids in immunosuppression after lung transplantation. Ann Thorac Surg 1995;59:277-82.
6. Tramontana JM, Utaipat U, Molloy A et al. Thalidomide treatment reduces tumor necrosis factor-α production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1995;1:384-97.
7. Sheskin J. Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 1965;6:303-6.
8. Grosshans E, Illy G. Thalidomide therapy for inflammatory dermatoses. Int J Dermatol 1984; 23:598-602.
9. Moller DR, Wysocka M, Greenlee BM et al. Inhibition of IL-12 production by thalidomide. J Immunol 1997;159:5157-61.
10. Issazadeh S, Ljungdahl Å, Höjeberg B, Mustafa M, Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β. J Neuroimmunol 1995;61:205-12.
11. Zhu J, Mix E, Link H. Cytokine production and the pathogenesis of experimental allergic neuritis and Guillain-Barré syndrome. J Neurommunol 1998;84:40-52.
12. Thornton CA, Griggs C. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol 1994; 35:749-52.
13. Zhu J, Bai XF, Mix E, van der Meide PH, Zwingenberger K, Link H. Thalidomide suppresses T and B cell response to myelin antigen in vitro in experimental allergic neuritis. Clin Neuropharmacol 1997;2:152-64.
14. Norton WI, Poduslo SE. Myelination in rat nerve: Method of myelin isolation. J Neurochem 1973;21:749-57.
15. Olee T, Powers JM, Brostoff SW. A T cell epitope for experimental allergic neuritis. J Neuroimmunol 1988;19:167-73.
16. Olsson T, Wang WZ, Höjeberg B et al. Autoreactive T lymphcytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J Clin Invest 1990;86:981-5.
17. Zhu J, Mix E, Olsson T, Link H. Cellular mRNA expression of interferon-b, interleukin 4 and transforming growth factor-β by rat mononuclear cells stimulated with peripheral nerve antigens in experimental allergic neuritis. Clin Exp Immunol 1994;98:06-12.
18. Crain E, McIntosh KR, Gordon G, Pestronk A, Drachman DB. The effect of thalidomide on experimental autoimmune myasthenia gravis. J Autoimmunity 1989;2:197-202.
19. Gardner-Medwin JM, Smith NJ, Powell RJ. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis 1994;53: 828-32.
20. Harland CC, Steventon GB, Marsden JR. Thalidomide-induced neuropathy and genetic differences in drug metabolism. Eur J Clin Pharmacol 1995;49:1-6.
21. Wulff CH, Hoyer H, Aaboe-Hansen G, Brodthagen H. Development of polyneuropathy during thalidomide therapy. Br J Dermatol 1985;112:475-80.
22. Gutierrez-Rodriguez O. A promising new treatment for rheumatoid arthritis. Arthritis Rheum 1984;27:1118-21.
23. Haslett PAJ, Corral LG, Albert M, Kaplan G. Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic response in the CD8+ subset. J Exp Med 1998;11:1885-92.
24. Hartung HP, Schäfer B, van der Meide PH, Fierz W, Heininger K, Toyka KV. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 1990;27:247-57.
25. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor a by enhancing mRNA degradation. J Exp Med 1993;177: 1675-80.
26. Hartung HP, Willison H, Jung S, Pette M, Toyka KV, Giegerich G. Autoimmune response in peripheral nerve. Springer Semin Immunopathol 1996;18:97-123.
27. Klausner JD, Freedman VH, Kaplan G. Thalidomide as an anti-TNF-inhibitor: implications for clinical use. Clin Immunol Immunopathol 1996;8:219-23.
28. Dijkema R, van der Meide HP, Dubbeld M, Wubben J, Schellekens H. Cloning expression and purification of rat IFN-γ. Methods Enzymol 1986;119:453-6.
29. Shirai T, Shimizu N, Horiguchi S, Jto H. Rat TNF alpha. Agric Biol Chem 1989;53:1733-6.
30. Mcknight AJ, Barclay AN, Mason DW. Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells. Eur J Immunol 1991;21:1187-94.
31. Moore KW, Vieia P, Fiorentino DF, Trounsteine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor(IL-10) to the Epstein-Barr Boris gene BCRFI. Science 1990;248:1230-4.
32. Derynck R, Jarett JA, Chen EY et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-5.